Figure 1. The outcomes before and after propensity matching (A) The 3-year survival before propensity matching (B) The 3-year recurrence-free survival (RFS) before propensity matching (C) The 3-year survival after propensity matching (D) The 3-year RFS after propensity matching.
Figure 2. Outcomes among advanced hepatocellular carcinoma (HCC) (A) The recurrence-free survival (RFS) among outside the Milan criteria (B) The recurrence rate (RR) among outside the Milan criteria (C) RFS among outside the Japan criteria (D) RR among outside the Japan criteria (E) RFS among higher HALT-HCC (F) RR among higher HALT-HCC.
Figure 3. The outcomes according to the donor and recipient liver immune status index (LISI) (A) In all cases (B) Outside the Milan criteria (C) Outside the Japan criteria (D) Higher HALT-hepatocellular carcinoma (HCC) score.
